AzTrials
AzTrials

Chronic MigraineNCT02627014

Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders

A study testing Manual therapy, Home physical therapy and Manual therapy in cervical region in people with Chronic Migraine and Temporomandibular Disorders, run by Cardenal Herrera University at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to determine whether treatment of temporomandibular joint is more effective than usual care in patients with chronic migraine and temporomandibular disorders to reduce pain. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Chronic Migraine, Temporomandibular Disorders
What is being tested?
Manual therapy, Home physical therapy and Manual therapy in cervical region
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteSpain
Study dates
Jul 2015to Mar 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Chronic migraine (ICHD_III beta, 2013)
  • Temporomandibular disorders (RDC/TMD)

Who cannot join

  • other neurological disease
  • psychiatric diseases
  • Physical therapy treatment in the last 6 months
  • dental treatment in the last 6 months
  • surgery or trauma in the orofacial region

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Universidad San Jorge

    Zaragoza

Other trials in Spain

About this study

The aim of this study is to determine whether treatment of temporomandibular joint is more effective than usual care in patients with chronic migraine and temporomandibular disorders to reduce pain.

Read the detailed description

The aim of this study is to determine whether treatment of temporomandibular joint added to the control group treatment and drug therapy patient base is more effective than just using the control group treatment and drug therapy in patients with chronic migraine and temporomandibular disorders to reduce pain and improve the quality of life related to health of patients.

Being tested
Manual therapy, Home physical therapy, Manual therapy in cervical region, Home physical therapy in cervical region
Keywords
Chronic Migraine, Temporomandibular Disorders, Physical Therapy, Manual Therapy, Home physical Therapy
Medical subject headings
Temporomandibular Joint Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Manual therapyOther

    6 treatments: 2 treatments for week

    1 treatment = 30 minutes

  • Home physical therapyOther

    once a day: 15 minutes

  • Manual therapy in cervical regionOther

    6 treatments: 2 treatments for week

    1 treatment = 30 minutes

  • Home physical therapy in cervical regionOther

    once a day: 15 minutes

Study groups in NCT02627014
Study groupRoleWhat they receive
INTERVENTIONExperimentalManual Therapy in temporomandibular joint and cervical region. Home physical therapy in temporomandibular joint and cervical region.
Receives: Other: Manual therapy; Other: Home physical therapy
CONTROLActive comparatorManual therapy in cervical region Home physical therapy in cervical region
Receives: Other: Manual therapy in cervical region; Other: Home physical therapy in cervical region

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Headache Impact Test (HIT-6)

    Measured: 3 months

Secondary outcomes (9)
  1. Visual Analogue Scale (VAS)

    Measured: 3 months

  2. Quality of life (SF-36)

    Measured: 3 months

  3. Sleep Quality

    Pittsburgh Sleep Quality Index

    Measured: 3 months

  4. Pain threshold pressure

    Pressure algometer in masticatory muscle (area trigeminal) and control point in area extra-trigeminal

    Measured: 3 months

  5. Pain catastrophizing scale (PCS)

    Measured: 3 months

  6. Craniofacial Pain and Disability Inventory (CF-PDI)

    Measured: 3 months

  7. Tampa scale of Kinesiophobia (TSK)

    Measured: 3 months

  8. Tampa scale of Kinesiophobia of cranio-mandibular disorder (TSK-TCM)

    Measured: 3 months

  9. Maximal Mouth Opening pain free

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2015 (estimated)
  2. Study startJul 2015
  3. Primary completionJan 2017
  4. Study completionMar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02627014
Sponsor's protocol ID
CM_TMD_1
Status last verified
Aug 2017
First submitted
4 Dec 2015
Last updated
8 Aug 2017
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Manual therapy, Home physical therapy and Manual therapy in cervical region in people with Chronic Migraine and Temporomandibular Disorders, run by Cardenal Herrera University at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Headache Impact Test (HIT-6) (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in